{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T18:54:45Z","timestamp":1789152885429,"version":"build-2803163510"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T00:00:00Z","timestamp":1771977600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T00:00:00Z","timestamp":1771977600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100005743","name":"Universit\u00e0 Cattolica del Sacro Cuore","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005743","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Targ Oncol"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1007\/s11523-026-01197-1","type":"journal-article","created":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T09:42:28Z","timestamp":1772012548000},"page":"285-297","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Concordance Analysis of Microsatellite Instability via NGS and Mismatch Repair Deficiency via IHC in Endometrial and Colorectal Cancer"],"prefix":"10.1007","volume":"21","author":[{"given":"Camilla","family":"Nero","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Salvatore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Duranti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2929-9328","authenticated-orcid":false,"given":"Gloria","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Mastrantoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mina","family":"Karimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Mantini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo","family":"Minucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Maneri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciano","family":"Giac\u00f2","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Santoro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arianna","family":"Panfili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Piermattei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilenia","family":"Marino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Caira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Alessandra","family":"Calegari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Trovato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Iacobelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanda","family":"Salutari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Normanno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Fanfani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Scambia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giampaolo","family":"Tortora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,25]]},"reference":[{"issue":"3","key":"1197_CR1","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1002\/gcc.23015","volume":"61","author":"MC Olave","year":"2022","unstructured":"Olave MC, Graham RP. Mismatch repair deficiency: the what, how and why it is important. Genes Chromosomes Cancer. 2022;61(3):314\u201321. https:\/\/doi.org\/10.1002\/gcc.23015.","journal-title":"Genes Chromosomes Cancer"},{"issue":"15","key":"1197_CR2","doi-asserted-by":"publisher","first-page":"8698","DOI":"10.1073\/pnas.95.15.8698","volume":"95","author":"ML Veigl","year":"1998","unstructured":"Veigl ML, Kasturi L, Olechnowicz J, Ma AH, Lutterbaugh JD, Periyasamy S, et al. Biallelic inactivation of hMLH1 by epigenetic gene silencing, a novel mechanism causing human MSI cancers. Proc Natl Acad Sci USA. 1998;95(15):8698\u2013702. https:\/\/doi.org\/10.1073\/pnas.95.15.8698.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"1197_CR3","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/nrclinonc.2009.237","volume":"7","author":"E Vilar","year":"2010","unstructured":"Vilar E, Gruber SB. Microsatellite instability in colorectal cancer: the stable evidence. Nat Rev Clin Oncol. 2010;7(3):153\u201362. https:\/\/doi.org\/10.1038\/nrclinonc.2009.237.","journal-title":"Nat Rev Clin Oncol"},{"issue":"18","key":"1197_CR4","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1056\/NEJMoa043146","volume":"352","author":"H Hampel","year":"2005","unstructured":"Hampel H, Frankel WL, Martin E, Arnold M, Khanduja K, Kuebler P, et al. Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer). N Engl J Med. 2005;352(18):1851\u201360. https:\/\/doi.org\/10.1056\/NEJMoa043146.","journal-title":"N Engl J Med"},{"issue":"3","key":"1197_CR5","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1136\/jmedgenet-2011-100714","volume":"49","author":"MT Parsons","year":"2012","unstructured":"Parsons MT, Buchanan DD, Thompson B, Young JP, Spurdle AB, Hopper JL, et al. Correlation of tumour BRAF mutations and MLH1 methylation with germline mismatch repair (MMR) gene mutation status: a literature review assessing utility of tumour features for MMR variant classification. J Med Genet. 2012;49(3):151\u20137. https:\/\/doi.org\/10.1136\/jmedgenet-2011-100714.","journal-title":"J Med Genet"},{"issue":"10","key":"1197_CR6","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.1038\/s41436-019-0536-8","volume":"21","author":"NAJ Ryan","year":"2019","unstructured":"Ryan NAJ, Glaire MA, Blake D, Cabrera-Dandy M, Evans DG, Crosbie EJ. The proportion of endometrial cancers associated with Lynch syndrome: a systematic review of the literature and meta-analysis. Genet Med. 2019;21(10):2167\u201380. https:\/\/doi.org\/10.1038\/s41436-019-0536-8.","journal-title":"Genet Med"},{"issue":"7447","key":"1197_CR7","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/nature12113","volume":"497","author":"C Kandoth","year":"2013","unstructured":"Cancer Genome Atlas Research Network, Kandoth C, Schultz N, Cherniack AD, Akbani R, Liu Y, et al. Integrated genomic characterization of endometrial carcinoma. Nature. 2013;497(7447):67\u201373. https:\/\/doi.org\/10.1038\/nature12113.","journal-title":"Nature"},{"issue":"7407","key":"1197_CR8","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1038\/nature11252","volume":"487","author":"C Kandoth","year":"2012","unstructured":"Cancer Genome Atlas Network, Network TCGA, Kandoth C, Schultz N, Cherniack AD, Akbani R, et al. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012;487(7407):330\u20137. https:\/\/doi.org\/10.1038\/nature11252.","journal-title":"Nature"},{"issue":"11","key":"1197_CR9","doi-asserted-by":"publisher","first-page":"1994","DOI":"10.3390\/genes14111994","volume":"14","author":"Y Wang","year":"2023","unstructured":"Wang Y, Shi C, Li X, Zhang Q, Chen J, Liu H, et al. Predicting prognosis and immunotherapy response in multiple cancers based on the association of PANoptosis-related genes with tumor heterogeneity. Genes (Basel). 2023;14(11):1994. https:\/\/doi.org\/10.3390\/genes14111994.","journal-title":"Genes (Basel)."},{"key":"1197_CR10","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s12935-019-1091-8","volume":"20","author":"K Li","year":"2020","unstructured":"Li K, Zhang L, Wang Y, Chen X, Liu H, Zhao J, et al. Microsatellite instability: a review of what the oncologist should know. Cancer Cell Int. 2020;20:16. https:\/\/doi.org\/10.1186\/s12935-019-1091-8.","journal-title":"Cancer Cell Int"},{"issue":"13","key":"1197_CR11","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1200\/JCO.2016.71.9807","volume":"35","author":"AR Sepulveda","year":"2017","unstructured":"Sepulveda AR, Hamilton SR, Allegra CJ, Grody WW, Cushman-Vokoun AM, Funkhouser WK, et al. Molecular biomarkers for the evaluation of colorectal cancer: guideline from the American Society for Clinical Pathology, College of American Pathologists, Association for Molecular Pathology, and the American Society of Clinical Oncology. J Clin Oncol. 2017;35(13):1453\u201386. https:\/\/doi.org\/10.1200\/JCO.2016.71.9807.","journal-title":"J Clin Oncol"},{"issue":"19","key":"1197_CR12","doi-asserted-by":"publisher","first-page":"3219","DOI":"10.1200\/JCO.2009.27.1825","volume":"28","author":"DJ Sargent","year":"2010","unstructured":"Sargent DJ, Marsoni S, Thibodeau SN, Labianca R, Hamilton SR, French AJ, et al. Defective mismatch repair as a predictive marker for lack of efficacy of fluorouracil-based adjuvant therapy in colon cancer. J Clin Oncol. 2010;28(19):3219\u201326. https:\/\/doi.org\/10.1200\/JCO.2009.27.1825.","journal-title":"J Clin Oncol"},{"issue":"5","key":"1197_CR13","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/S1470-2045(22)00197-8","volume":"23","author":"LA Diaz","year":"2022","unstructured":"Diaz LA, Shiu KK, Kim TW, Jensen BV, Jensen LH, Punt C, et al. Pembrolizumab versus chemotherapy for microsatellite instability-high or mismatch repair-deficient metastatic colorectal cancer (KEYNOTE-177): final analysis of a randomised, open-label, phase 3 study. Lancet Oncol. 2022;23(5):659\u201370. https:\/\/doi.org\/10.1016\/S1470-2045(22)00197-8.","journal-title":"Lancet Oncol"},{"key":"1197_CR14","unstructured":"European Society of Gynaecological Oncology (ESGO). ESGO-ESTRO-ESP cervical cancer guidelines. Published May 1, 2023. https:\/\/guidelines.esgo.org. Accessed 31 Jan 2026."},{"key":"1197_CR15","unstructured":"Merck Sharp & Dohme LLC. Study of pembrolizumab (MK-3475) in participants with advanced solid tumors (KEYNOTE-158). ClinicalTrials.gov identifier: NCT02628067. Published December 17, 2015. Updated May 16, 2023. Available from: https:\/\/clinicaltrials.gov\/study\/NCT02628067. Accessed 5 Sept 2024."},{"key":"1197_CR16","unstructured":"GlaxoSmithKline. Study to evaluate the efficacy and safety of dostarlimab in combination with carboplatin-paclitaxel in participants with recurrent or primary advanced endometrial cancer (RUBY). ClinicalTrials.gov identifier: NCT03981796. Published June 11, 2019. Updated May 7, 2024. https:\/\/clinicaltrials.gov\/study\/NCT03981796.  Accessed 5 Sept 2024."},{"key":"1197_CR17","unstructured":"GlaxoSmithKline. Study of dostarlimab (TSR-042) in participants with recurrent or advanced solid tumors (GARNET). ClinicalTrials.gov identifier: NCT02715284. Published March 14, 2016. Updated August 1, 2023. https:\/\/clinicaltrials.gov\/study\/NCT02715284. Accessed 5 Sept 2024."},{"key":"1197_CR18","unstructured":"Merck Sharp & Dohme LLC. Lenvatinib in combination with pembrolizumab in advanced endometrial cancer (Study 309\/KEYNOTE-775). ClinicalTrials.gov identifier: NCT03517449. Published May 7, 2018. Updated July 25, 2023. https:\/\/clinicaltrials.gov\/study\/NCT03517449. Accessed 5 Sept 2024."},{"issue":"8","key":"1197_CR19","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1016\/j.annonc.2022.05.009","volume":"33","author":"A Oaknin","year":"2022","unstructured":"Oaknin A, Colombo N, Creutzberg C, Gressel GM, Harter P, Joly F, et al. Endometrial cancer: ESMO clinical practice guideline for diagnosis, treatment and follow-up. Ann Oncol. 2022;33(8):860\u201377. https:\/\/doi.org\/10.1016\/j.annonc.2022.05.009.","journal-title":"Ann Oncol"},{"issue":"1","key":"1197_CR20","first-page":"33","volume":"32","author":"J Ferguson","year":"2014","unstructured":"Ferguson J, Grothey A, Kerr D, Thibodeau S, Goldberg RM, Sargent DJ, et al. Immunohistochemistry (IHC) for MMR proteins: a reliable method for identifying mismatch repair deficiency in colorectal cancers. J Clin Oncol. 2014;32(1):33\u201345.","journal-title":"J Clin Oncol"},{"issue":"8","key":"1197_CR21","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1093\/annonc\/mdz116","volume":"30","author":"C Luchini","year":"2019","unstructured":"Luchini C, Bibeau F, Ligtenberg MJL, Bosse T, Miller K, La Rosa S, et al. ESMO recommendations on microsatellite instability testing for immunotherapy in cancer, and its relationship with PD-1\/PD-L1 expression and tumour mutational burden: a systematic review-based approach. Ann Oncol. 2019;30(8):1232\u201343. https:\/\/doi.org\/10.1093\/annonc\/mdz116.","journal-title":"Ann Oncol"},{"issue":"9","key":"1197_CR22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003263","volume":"17","author":"NAJ Ryan","year":"2020","unstructured":"Ryan NAJ, McMahon R, Tobi S, Snowsill T, Evans DG, Crosbie EJ, et al. The proportion of endometrial tumours associated with Lynch syndrome (PETALS): a prospective cross-sectional study. PLoS Med. 2020;17(9):e1003263. https:\/\/doi.org\/10.1371\/journal.pmed.1003263.","journal-title":"PLoS Med"},{"issue":"1","key":"1197_CR23","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s40880-019-0388-2","volume":"39","author":"X Chao","year":"2019","unstructured":"Chao X, Li L, Wu M, Wang Y, Zhang Q, Liu H, et al. Comparison of screening strategies for Lynch syndrome in patients with newly diagnosed endometrial cancer: a prospective cohort study in China. Cancer Commun (Lond). 2019;39(1):42. https:\/\/doi.org\/10.1186\/s40880-019-0388-2.","journal-title":"Cancer Commun (Lond)."},{"issue":"3","key":"1197_CR24","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1007\/s00428-021-03082-w","volume":"479","author":"I Ukkola","year":"2021","unstructured":"Ukkola I, Nummela P, Pasanen A, Peltom\u00e4ki P, Aaltonen LA, Vahteristo P, et al. Detection of microsatellite instability with Idylla MSI assay in colorectal and endometrial cancer. Virchows Arch. 2021;479(3):471\u20139. https:\/\/doi.org\/10.1007\/s00428-021-03082-w.","journal-title":"Virchows Arch"},{"issue":"6","key":"1197_CR25","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.3390\/cancers13061268","volume":"13","author":"J Siemanowski","year":"2021","unstructured":"Siemanowski J, Sch\u00f6mig-Markiefka B, Buhl T, St\u00f6hr R, Schauer S, Kr\u00fcger S, et al. Managing difficulties of microsatellite instability testing in endometrial cancer: limitations and advantages of four different PCR-based approaches. Cancers (Basel). 2021;13(6):1268. https:\/\/doi.org\/10.3390\/cancers13061268.","journal-title":"Cancers (Basel)."},{"issue":"1","key":"1197_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-73421-5","volume":"10","author":"P Gilson","year":"2020","unstructured":"Gilson P, Levy J, Rouyer M, Demange J, Husson M, Bonnet C, et al. Evaluation of 3 molecular-based assays for microsatellite instability detection in formalin-fixed tissues of patients with endometrial and colorectal cancers. Sci Rep. 2020;10(1):16386. https:\/\/doi.org\/10.1038\/s41598-020-73421-5.","journal-title":"Sci Rep"},{"issue":"23","key":"1197_CR27","doi-asserted-by":"publisher","first-page":"3970","DOI":"10.3390\/cancers16233970","volume":"16","author":"P Sowter","year":"2024","unstructured":"Sowter P, Maxwell P, Quek RGW, Speirs V, McVeigh T, Sch\u00f6mig-Markiefka B, et al. Detection of mismatch repair deficiency in endometrial cancer using the Newcastle MSI assay: concordance with IHC and significance of MSH6 status. Cancers (Basel). 2024;16(23):3970. https:\/\/doi.org\/10.3390\/cancers16233970.","journal-title":"Cancers (Basel)"},{"issue":"3","key":"1197_CR28","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1002\/cncr.35030","volume":"130","author":"CJ Riedinger","year":"2024","unstructured":"Riedinger CJ, Esnakula A, Haight PJ, Suarez AA, Chen W, Gillespie J, et al. Characterization of mismatch-repair\/microsatellite instability-discordant endometrial cancers. Cancer. 2024;130(3):385\u201399. https:\/\/doi.org\/10.1002\/cncr.35030.","journal-title":"Cancer"},{"issue":"1","key":"1197_CR29","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.jmoldx.2016.07.008","volume":"19","author":"Y Wang","year":"2017","unstructured":"Wang Y, Shi C, Eisenberg R, Vnencak-Jones CL. Differences in microsatellite instability profiles between endometrioid and colorectal cancers: a potential cause for false-negative results? J Mol Diagn. 2017;19(1):57\u201364. https:\/\/doi.org\/10.1016\/j.jmoldx.2016.07.008.","journal-title":"J Mol Diagn"},{"issue":"5","key":"1197_CR30","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1038\/s41379-018-0179-3","volume":"32","author":"X Wu","year":"2019","unstructured":"Wu X, Snir O, Rottmann D, Wong S, Buza N, Hui P. Minimal microsatellite shift in microsatellite instability high endometrial cancer: a significant pitfall in diagnostic interpretation. Mod Pathol. 2019;32(5):650\u20138. https:\/\/doi.org\/10.1038\/s41379-018-0179-3.","journal-title":"Mod Pathol"},{"issue":"11","key":"1197_CR31","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1038\/nm.4191","volume":"22","author":"RJ Hause","year":"2016","unstructured":"Hause RJ, Pritchard CC, Shendure J, Salipante SJ, Niu B, Mardis ER, et al. Classification and characterization of microsatellite instability across 18 cancer types. Nat Med. 2016;22(11):1342\u201350. https:\/\/doi.org\/10.1038\/nm.4191.","journal-title":"Nat Med"},{"issue":"2","key":"1197_CR32","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.jmoldx.2017.11.007","volume":"20","author":"L Zhu","year":"2018","unstructured":"Zhu L, et al. A novel and reliable method to detect microsatellite instability in colorectal cancer by next-generation sequencing. J Mol Diagn. 2018;20(2):225\u201331. https:\/\/doi.org\/10.1016\/j.jmoldx.2017.11.007.","journal-title":"J Mol Diagn"},{"issue":"3","key":"1197_CR33","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25021056","volume":"25","author":"F Addante","year":"2024","unstructured":"Addante F, et al. Mismatch repair deficiency as a predictive and prognostic biomarker in endometrial cancer: a review on immunohistochemistry staining patterns and clinical implications. Int J Mol Sci. 2024;25(3):1056. https:\/\/doi.org\/10.3390\/ijms25021056.","journal-title":"Int J Mol Sci"},{"issue":"15","key":"1197_CR34","doi-asserted-by":"publisher","first-page":"2898","DOI":"10.1002\/cncr.34331","volume":"128","author":"C Nero","year":"2022","unstructured":"Nero C, et al. Further refining 2020 ESGO\/ESTRO\/ESP molecular risk classes in patients with early-stage endometrial cancer: a propensity score-matched analysis. Cancer. 2022;128(15):2898\u2013907. https:\/\/doi.org\/10.1002\/cncr.34331.","journal-title":"Cancer"},{"issue":"6","key":"1197_CR35","doi-asserted-by":"publisher","DOI":"10.3390\/jpm12101746","volume":"12","author":"C Nero","year":"2022","unstructured":"Nero C, et al. Integrating a comprehensive cancer genome profiling into clinical practice: a blueprint in an Italian referral center. J Pers Med. 2022;12(6):1746. https:\/\/doi.org\/10.3390\/jpm12101746.","journal-title":"J Pers Med"},{"key":"1197_CR36","unstructured":"Illumina, Inc. TruSight Oncology 500: tumor mutational burden (TMB) analysis. Published 2018. https:\/\/www.illumina.com\/content\/dam\/illumina-marketing\/documents\/products\/appnotes\/trusight-oncology-500-tmb-analysis-1170-2018-009.pdf. Accessed 5 Sept 2024."},{"issue":"7793","key":"1197_CR37","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/s41586-020-1943-3","volume":"578","author":"LB Alexandrov","year":"2020","unstructured":"Alexandrov LB, et al. The repertoire of mutational signatures in human cancer. Nature. 2020;578(7793):94\u2013101. https:\/\/doi.org\/10.1038\/s41586-020-1943-3.","journal-title":"Nature"},{"issue":"18","key":"1197_CR38","doi-asserted-by":"publisher","first-page":"2847","DOI":"10.1093\/bioinformatics\/btw313","volume":"32","author":"Z Gu","year":"2016","unstructured":"Gu Z, et al. Complex heatmaps reveal patterns and correlations in multidimensional genomic data. Bioinformatics. 2016;32(18):2847\u20139. https:\/\/doi.org\/10.1093\/bioinformatics\/btw313.","journal-title":"Bioinformatics"},{"issue":"19","key":"1197_CR39","doi-asserted-by":"publisher","first-page":"2811","DOI":"10.1093\/bioinformatics\/btu393","volume":"30","author":"Z Gu","year":"2014","unstructured":"Gu Z, et al. Circlize implements and enhances circular visualization in R. Bioinformatics. 2014;30(19):2811\u20132. https:\/\/doi.org\/10.1093\/bioinformatics\/btu393.","journal-title":"Bioinformatics"},{"issue":"12","key":"1197_CR40","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1101\/gr.239244.118","volume":"28","author":"A Mayakonda","year":"2018","unstructured":"Mayakonda A, et al. Maftools: efficient and comprehensive analysis of somatic variants in cancer. Genome Res. 2018;28(12):1747\u201356. https:\/\/doi.org\/10.1101\/gr.239244.118.","journal-title":"Genome Res"},{"key":"1197_CR41","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-24277-4","volume-title":"ggplot2: elegant graphics for data analysis","author":"H Wickham","year":"2016","unstructured":"Wickham H. ggplot2: elegant graphics for data analysis. New York: Springer; 2016."},{"key":"1197_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-91974-x","volume":"11","author":"F Dedeurwaerdere","year":"2021","unstructured":"Dedeurwaerdere F, et al. Comparison of microsatellite instability detection by immunohistochemistry and molecular techniques in colorectal and endometrial cancer. Sci Rep. 2021;11:12880. https:\/\/doi.org\/10.1038\/s41598-021-91974-x.","journal-title":"Sci Rep"},{"key":"1197_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2022.153874","volume":"233","author":"SY Kang","year":"2022","unstructured":"Kang SY, et al. Comparative analysis of microsatellite instability by next-generation sequencing, MSI PCR and MMR immunohistochemistry in 1942 solid cancers. Pathol Res Pract. 2022;233:153874. https:\/\/doi.org\/10.1016\/j.prp.2022.153874.","journal-title":"Pathol Res Pract"},{"issue":"1","key":"1197_CR44","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1093\/annonc\/mdw542","volume":"28","author":"E Stelloo","year":"2017","unstructured":"Stelloo E, et al. Practical guidance for mismatch repair-deficiency testing in endometrial cancer. Ann Oncol. 2017;28(1):96\u2013102. https:\/\/doi.org\/10.1093\/annonc\/mdw542.","journal-title":"Ann Oncol"},{"issue":"5","key":"1197_CR45","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1038\/s41379-021-00918-3","volume":"35","author":"M Jaffrelot","year":"2022","unstructured":"Jaffrelot M, et al. An unusual phenotype occurs in 15% of mismatch repair-deficient tumors and is associated with non-colorectal cancers and genetic syndromes. Mod Pathol. 2022;35(5):427\u201337. https:\/\/doi.org\/10.1038\/s41379-021-00918-3.","journal-title":"Mod Pathol"},{"key":"1197_CR46","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2020.00122","volume":"7","author":"N Pe\u0107ina-\u0160laus","year":"2020","unstructured":"Pe\u0107ina-\u0160laus N, et al. Mismatch repair pathway, genome stability and cancer. Front Mol Biosci. 2020;7:122. https:\/\/doi.org\/10.3389\/fmolb.2020.00122.","journal-title":"Front Mol Biosci"},{"key":"1197_CR47","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1628979","volume":"16","author":"C Wang","year":"2025","unstructured":"Wang C, Feng M, Kou Y, Kuang W, Wang W, Liang D. Evaluation of microsatellite instability patterns in mismatch repair deficiency: a retrospective analysis of 285 endometrial cancers. Front Immunol. 2025;16:1628979. https:\/\/doi.org\/10.3389\/fimmu.2025.1628979.","journal-title":"Front Immunol"},{"issue":"7","key":"1197_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.modpat.2025.100757","volume":"38","author":"NC Helderman","year":"2025","unstructured":"Helderman NC, Strobel F, Bohaumilitzky L, Terlouw D, van der Werf-\u2019t Lam AS, van Wezel T, et al. Lower degree of microsatellite instability in colorectal carcinomas from MSH6-associated Lynch syndrome patients. Mod Pathol. 2025;38(7):100757. https:\/\/doi.org\/10.1016\/j.modpat.2025.100757.","journal-title":"Mod Pathol"}],"container-title":["Targeted Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11523-026-01197-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11523-026-01197-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11523-026-01197-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T16:57:50Z","timestamp":1774630670000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11523-026-01197-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,25]]},"references-count":48,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["1197"],"URL":"https:\/\/doi.org\/10.1007\/s11523-026-01197-1","relation":{},"ISSN":["1776-2596","1776-260X"],"issn-type":[{"value":"1776-2596","type":"print"},{"value":"1776-260X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,25]]},"assertion":[{"value":"6 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Camilla Nero has received travel support from MSD, Illumina, Menarini, and AstraZeneca, and honoraria from Veeva, GSK, MSD, AstraZeneca, Altems, Illumina, and Guardant Health. Lisa Salvatore has served as a consultant or advisor for Amgen, AstraZeneca, Bristol-Myers Squibb, Daiichi-Sankyo, Incyte, Lilly, Merck Serono, MSD, and Servier. She has also received research funding from Amgen, Astellas, AstraZeneca, Bayer, BMS, Daiichi-Sankyo, Hutchinson, Incyte, Merck Serono, Mirati, MSD, Pfizer, and Roche. She is part of the speakers\u2019 bureaus of Amgen, Bristol-Myers Squibb, GlaxoSmithKline, Lilly, Merck Serono, Pierre Fabre, Roche, and Servier. Maria Alessandra Calegari has received travel and hospitality support from Pierre Fabre, Amgen, Merck, Servier, and Bayer. He also participates in the advisory board of Merck. Vanda Salutari has received honoraria or consultation fees from Immunogen, MSD, GSK, Menarini, and Steam Line, and participated in company-sponsored speaker\u2019s bureaus for MSD, AstraZeneca, GSK, and EISAI. Nicola Normanno declares receiving speaker\u2019s fees and\/or participating in advisory boards for MSD, Bayer, Biocartis, Illumina, Incyte, Roche, BMS, Merck, Thermo Fisher, AstraZeneca, and Eli Lilly. He also received financial support for research projects (institutional grants) from Merck, Thermo Fisher, QIAGEN, Roche, AstraZeneca, Biocartis, and Illumina. He has non-financial interests as the President of the International Quality Network for Pathology (IQN Path) and as the Past President of the Italian Cancer Society (SIC). Francesco Fanfani has received research funding from Clovis, GSK, MSD, and PharmaMar, as well as personal and financial interests with GSK, MSD, SYSMEX, and STRYKER. Giovanni Scambia has received research support from MSD and honoraria from Clovis Oncology, and serves as a consultant for Tesaro and Johnson & Johnson. Giovanni Trovato has participated in advisory boards and sponsored meetings organized by BMS, MSD, Merck, AstraZeneca, Pfizer, Servier, Roche, and Domp\u00e9. Simona Duranti, Gloria Anderson, Luca Mastrantoni, Mina Karimi, Giulia Mantini, Angelo Minucci, Giulia Maneri, Luciano Giac\u00f2, Angela Santoro, Arianna Panfili, Alessia Piermattei, Ilenia Marino, Giulia Caira, Giovanni Trovato, and Valentina Iacobelli have no conflicts of interest that are directly relevant to the content of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study has been conducted following the Declaration of Helsinki and has received approval from the Fondazione Policlinico Universitario \u201cA. Gemelli\u201d IRCCS ethical committee (Protocol U 00194\/23, ID number: 3837).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Prior to participation, all patients provided informed consent.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The datasets generated and analyzed during the current study are not publicly available because of ethical reasons, but are available from the corresponding author on reasonable request.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and material"}},{"value":"Not applicable","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}}]}}